How to Start Ozempic Pen for Weight Loss: A Comprehensive Guide

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection therapy activates GLP-1 receptors in your brain to decrease hunger signals and slow stomach emptying, creating the metabolic conditions for sustainable weight loss. Starting this medication requires understanding the initiation protocol, potential side effects, and how to integrate it into your lifestyle. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, serving all 50 states without insurance requirements or membership fees.

Understanding Semaglutide Injection Therapy for Weight Management

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management. Clinical trials have shown that semaglutide injections produce average weight loss of 10–15% of body weight over 68 weeks in people without diabetes. The medication works by binding to GLP-1 receptors throughout your body, particularly in areas of the brain that regulate appetite, satiety, and energy expenditure.

Unlike oral formulations, injectable semaglutide enters the bloodstream directly, allowing for more predictable absorption and potentially greater efficacy at lower doses. Patients typically notice reduced cravings within the first two weeks and sustained appetite suppression as their body adapts to the therapy. The effect is reversible—when you stop taking semaglutide, hunger and appetite hormones gradually return to baseline over several weeks.

The Semaglutide Starting Protocol and Dose Escalation Schedule

Most semaglutide injection programs begin with a low starting dose of 0.25 mg once weekly, administered subcutaneously (under the skin) in the abdomen, thigh, or upper arm. The dose increases gradually every four weeks in 0.25 mg increments—a strategy designed to allow your body to adapt and minimize nausea and gastrointestinal side effects. Typical progression moves from 0.25 mg to 0.5 mg to 1.0 mg and potentially up to 2.4 mg weekly, with each step separated by a full month to assess tolerability.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What to Expect During Your First Month on Semaglutide Injections

During week one of semaglutide therapy, most patients experience mild to moderate nausea, particularly if they consume large meals or high-fat foods. This initial response typically peaks at days 2–3 after the first injection and subsides significantly by day 5 as your body acclimates. Adopting smaller, protein-forward meals and staying hydrated helps reduce nausea; many patients find that ginger tea, peppermint, or eating slowly dramatically improves their comfort.

By the end of week two, appetite suppression becomes noticeable—you may feel satisfied after eating half your normal portion, or forget to eat lunch because hunger signals are muted. Some patients experience changes in how foods taste or smell, and certain previously favorite foods may become unappealing. These early changes stabilize by week three, and most people report that nausea has resolved while appetite control remains strong and consistent.

Accessing Semaglutide Injections Through PlexusDx: Pricing and Convenience

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with pricing that remains flat regardless of your dose level as it increases throughout your treatment journey. Your dose may need to go up. Your price won't. All medications are sourced from licensed 503A compounding pharmacies and comply with state and federal regulations; patients receive their injections shipped directly to their home with clear instructions on storage and administration.

PlexusDx serves all 50 states and does not require insurance, membership fees, or prior authorization hurdles. HSA and FSA accounts are eligible for payment, making semaglutide therapy accessible to people across different financial circumstances. After your first month of treatment, you may add the Precision Peptide Genetic Test for $298, which provides personalized insights into your peptide-pathway genetics and helps optimize your long-term weight loss strategy.

Safety, Side Effects, and When to Contact Your Healthcare Provider

Common side effects of semaglutide injections include nausea, vomiting, constipation, diarrhea, and fatigue, with most occurring during the first 2–4 weeks as your body adapts. Serious side effects are rare but include severe abdominal pain, rapid heartbeat, fainting, or signs of thyroid cancer (persistent hoarseness, difficulty swallowing, or neck lumps). Semaglutide should not be used if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Constipation affects approximately 20–30% of semaglutide users and can be managed with increased water intake, dietary fiber, and over-the-counter stool softeners. If you experience severe nausea, persistent vomiting, signs of pancreatitis (severe upper abdominal pain), or gallbladder issues, contact your prescribing clinician immediately. Regular follow-up appointments help ensure your dose escalation remains appropriate and that any emerging concerns are addressed promptly.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide injections?

Most patients notice appetite suppression within the first 1–2 weeks, with measurable weight loss appearing around week 3–4 as they consistently eat fewer calories. Average weight loss ranges from 10–15% of body weight over 16–17 weeks in clinical trials, though individual results vary significantly based on lifestyle, metabolism, and adherence. PlexusDx clinicians monitor your progress monthly and adjust your dose to optimize results while maintaining safety.

Can I switch from oral semaglutide to injections with PlexusDx?

Yes, many patients transition from oral to injectable semaglutide because injections deliver more consistent blood levels and typically produce better weight loss outcomes. If you've been taking oral semaglutide, your clinician at PlexusDx will reset your starting dose to 0.25 mg injection and titrate upward as before, since injection and oral formulations have different absorption profiles. This transition typically occurs without loss of appetite control or unwanted rebound hunger.

What does PlexusDx semaglutide injection cost, and does insurance cover it?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with flat pricing across all dose levels. PlexusDx does not require insurance and works independently of insurance companies, though HSA and FSA funds are accepted for payment. No membership fees, prior authorization delays, or surprise charges apply—your monthly cost stays the same whether you're at 0.25 mg or 2.4 mg.

Is compounded semaglutide as safe and effective as brand-name Ozempic?

PlexusDx semaglutide is compounded by licensed 503A pharmacies under strict quality standards and contains the same active pharmaceutical ingredient as brand-name Ozempic. While compounded medications are not FDA-approved as a category, 503A compounding is federally regulated and inspected; many patients choose compounded options for cost savings and accessibility. Clinical outcomes are comparable when compound quality is assured and dosing is supervised by qualified clinicians.

How does the Precision Peptide Genetic Test help personalize my semaglutide therapy?

PlexusDx Precision Peptide Genetic Test analyzes variants in GIPR and FTO, and MC4R genes that influence how your body responds to GLP-1 therapy and weight loss interventions. The test maps 14 metabolic pathways and 49 peptides to reveal whether you may be a responder to higher-dose semaglutide, whether constipation or nausea is more likely, and which dietary or lifestyle modifications complement your genetic predispositions. Adding this $298 test after your first month of treatment helps optimize your long-term success and reduces trial-and-error dosing.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.